mHealth Technology and CVD Risk Reduction.
Maan Isabella CajitaYaguang ZhengJacob Kigo KariukiKaren M VuckovicLora E BurkePublished in: Current atherosclerosis reports (2021)
A total of 50 articles are included in this review. The majority of the mHealth interventions targeted a specific CVD risk factor, while 4 addressed 2 or more CVD risk factors. Of the 9 mHealth-supported weight loss intervention trials, 4 resulted in significant weight loss. Four out of 7 RCTs targeting improvement in physical activity reported significant improvement, while 4 of the 8 mHealth-supported smoking cessation intervention trials resulted in smoking abstinence. Of the 10 mHealth-based diabetes intervention trials, 5 reported significant reductions in HbA1c; however, only 3 out of the 9 antihypertension interventions resulted in significant reductions in blood pressure. There is a growing body of literature focused on mHealth interventions that address CVD risk factors. Despite the immense potential of mHealth interventions, evidence of their efficacy in mitigating cardiovascular risk is heterogeneous.
Keyphrases
- risk factors
- smoking cessation
- physical activity
- weight loss
- randomized controlled trial
- blood pressure
- bariatric surgery
- type diabetes
- systematic review
- roux en y gastric bypass
- body mass index
- cardiovascular disease
- cancer therapy
- gastric bypass
- metabolic syndrome
- glycemic control
- insulin resistance
- adipose tissue
- drug delivery
- obese patients